Edesa Biotech Company Insiders

Edesa Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.5702) % which means that it has lost $0.5702 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9957) %, meaning that it created substantial loss on money invested by shareholders. Edesa Biotech's management efficiency ratios could be used to measure how well Edesa Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of January 7, 2026, Return On Tangible Assets is expected to decline to -0.7. In addition to that, Return On Capital Employed is expected to decline to -0.53. At present, Edesa Biotech's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 8.8 M. The current year's Common Stock Shares Outstanding is expected to grow to about 6.9 M, whereas Net Loss is projected to grow to (15 M). The market capitalization of Edesa Biotech is $12.42 Million. 30% of Edesa Biotech outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as Edesa Biotech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Edesa Biotech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Edesa Biotech Workforce Comparison

Edesa Biotech Insider Trading

Edesa Biotech Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Edesa Biotech often depends on how effective the management is. Edesa Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Edesa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Edesa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Edesa Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Edesa Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Edesa Biotech's management manipulating its earnings.

When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.